Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 1 11Phase 1/2 7Phase 3 5Phase NA 2Phase 2/3 1

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 9Sarcoma 5Gynecologic 1

Conditions

Sarcoma 4Neoplasm Metastasis 1Hemangiosarcoma 1

Interventions

Doxorubicin 40Radiotherapy 30Ifosfamide 28Vincristine 27Cyclophosphamide 24Imatinib Mesylate 20Etoposide 20Dactinomycin 14Radiation 13Filgrastim 11Temozolomide 9Sunitinib 9Trabectedin 8Methotrexate 8Specimen Handling 7Magnetic Resonance Spectroscopy 6Granulocyte Colony-Stimulating Factor 6Chemotherapy, Adjuvant 6pazopanib 5nilotinib 5Zoledronic Acid 5Neoadjuvant Therapy 5Irinotecan 5Cisplatin 5Carboplatin 5X-Rays 4Vinorelbine 4Topotecan 4Surgical Procedures, Operative 4Procarbazine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × pazopanib × Sarcoma × Clear all
NCT06263231 2025-07-29

INVINCIBLE-3

Intensity Therapeutics, Inc.

Phase 3 Active not recruiting
333 enrolled
Sarcoma

Sarcoma

NCT02049905 2024-06-13

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

ImmunityBio, Inc.

Phase 3 Completed
433 enrolled 10 charts
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT04741438 2023-08-30

RAR-Immune

Centre Leon Berard

Phase 3 Unknown
96 enrolled
Sarcoma

Sarcoma

NCT02979899 2020-05-12

TAPPAS

Tracon Pharmaceuticals Inc.

Phase 3 Completed
128 enrolled 13 charts
Sarcoma

Hemangiosarcoma

NCT00753688 2013-08-22

PALETTE

GlaxoSmithKline

Phase 3 Completed
369 enrolled 17 charts
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡